Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 784.686 T ARS | 17,450.000 ARS | +4.65% | 15.644 K | 1.26 | 139.76 | 124.85 ARS | +564.33% | 0.40% | Health technology | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 784.686 T ARS | 15.650 USD | +2.29% | 570 | 0.63 | 121.46 | 124.85 ARS | +178.70% | 0.40% | Health technology | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 372.081 T ARS | 1,340.000 ARS | −16.25% | 6 K | 1,578.95 | — | — | — | — | Health technology | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 372.081 T ARS | 12,025.000 ARS | −1.64% | 7.977 K | 1.30 | 39.18 | 306.92 ARS | +257.75% | 1.33% | Health technology | — |
DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 372.081 T ARS | 1.300 USD | −3.70% | 2 | 0.00 | — | — | — | — | Health technology | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 372.081 T ARS | 10.900 USD | −0.91% | 3.162 K | 1.93 | 34.41 | 306.92 ARS | +50.08% | 1.33% | Health technology | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 350.442 T ARS | 23,150.000 ARS | −0.64% | 270 | 0.26 | 9.88 | 2,343.37 ARS | +183.01% | 1.76% | Health technology | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 350.442 T ARS | 21.000 USD | +1.94% | 52 | 0.38 | 8.68 | 2,343.37 ARS | +18.73% | 1.76% | Health technology | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 258.797 T ARS | 23,875.000 ARS | +0.84% | 1.576 K | 0.34 | 27.03 | 883.37 ARS | +899.22% | 1.45% | Health technology | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 258.797 T ARS | 22.000 USD | −0.68% | 17 | 0.45 | 24.13 | 883.37 ARS | +319.19% | 1.45% | Health technology | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 209.526 T ARS | 30,725.000 ARS | −0.89% | 48 | 0.16 | 3.54 | 8,672.72 ARS | +474.20% | 3.55% | Health technology | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 198.181 T ARS | 37,375.000 ARS | −0.66% | 1.147 K | 0.74 | 66.64 | 560.88 ARS | +283.52% | 1.53% | Health technology | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 198.181 T ARS | 31.100 USD | −8.53% | 4 | 0.30 | 79.21 | 560.88 ARS | −23.30% | 1.53% | Health technology | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 150.519 T ARS | 7,770.000 ARS | −2.88% | 16.141 K | 0.72 | 33.10 | 234.71 ARS | +224.10% | 3.23% | Health technology | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 150.519 T ARS | 7.060 USD | −1.26% | 2.53 K | 0.61 | 29.15 | 234.71 ARS | +35.96% | 3.23% | Health technology | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 109.151 T ARS | 20,850.000 ARS | −2.80% | 832 | 1.41 | — | −3,485.27 ARS | −317.45% | 4.43% | Health technology | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 109.151 T ARS | 18.100 USD | +1.12% | 9 | 0.17 | — | −3,485.27 ARS | −191.22% | 4.43% | Health technology | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 72.715 T ARS | 10,550.000 ARS | −0.94% | 362 | 0.56 | 34.27 | 307.84 ARS | +49.45% | 2.47% | Health technology | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 25.065 T ARS | 15,350.000 ARS | −1.29% | 260 | 0.39 | 22.07 | 695.64 ARS | +368.68% | 0.00% | Health technology | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 25.065 T ARS | 14.000 USD | +0.72% | 40 | 1.71 | 19.50 | 695.64 ARS | +96.62% | 0.00% | Health technology | — |
RICHLABORATORIOS RICHMOND SACIF | 157.869 B ARS | 1,955.000 ARS | +14.33% | 73.513 K | 1.45 | 883.02 | 2.21 ARS | — | 0.00% | Health technology | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.246 B ARS | 99.700 ARS | +2.78% | 8.761 K | 1.68 | 6.13 | 16.26 ARS | — | 0.00% | Health technology | — |